No profile data available.
America Great Health (AAGH) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Alhambra, United States, with about 5 full-time employees.
It reported revenue of $391,743 for fiscal year 2025, up 32.9% from fiscal year 2024, and net income of -$719,119. In Q3 2026 (the quarter ended March 31, 2026) revenue was $26,143, down 53.4% from a year before. Its market capitalization was $6.35 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 8, 2026.
America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements.
America Great Health reported $391,743 in revenue for fiscal year 2025, up 32.9% from $294,670 in fiscal year 2024. In Q3 2026 revenue was $26,143.
$6.35 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Can-Fite BioPharma Ltd. (CANF), OSR Holdings, Inc. (OSRH), VitaSpring Biomedical Co. Ltd. (VSBC), Scienture Holdings, Inc. (SCNX).